Issue 3/2009
Content (13 Articles)
Nesiritide, Heart Failure, and Renal Dysfunction: Irrational Exuberance or Throwing the Baby out with the Bathwater
Ronald M. Witteles
Pharmacological Approaches to Modifying HDL: More Basic Science to Understand HDL Metabolism is Necessary
Michael H. Davidson
Dofetilide as Activator of Na/Ca Exchange: New Perspectives on an ‘Old’ Drug
Gudrun Antoons, Karin R. Sipido
Remote Postconditioning is More Potent than Classic Postconditioning in Reducing the Infarct Size in Anesthetized Rabbits
G. Gritsopoulos, E. K. Iliodromitis, A. Zoga, D. Farmakis, E. Demerouti, A. Papalois, I. A. Paraskevaidis, D. T. Kremastinos
NO-1886 Up-regulates Niemann–Pick C1 Protein (NPC1) Expression Through Liver X Receptor α Signaling Pathway in THP-1 Macrophage-Derived Foam Cells
Xin Ma, Yan-Wei Hu, Zhong-Cheng Mo, Xiao-Xu Li, Xie-Hong Liu, Ji Xiao, Wei-Dong Yin, Duan-Fang Liao, Chao-Ke Tang
Dofetilide Enhances the Contractility of Rat Ventricular Myocytes via Augmentation of Na+–Ca2+ Exchange
Xuan-Ping Zhang, Bo-Wei Wu, Cai-Hong Yang, Jie Wang, Shuan-Cheng Niu, Ming-Sheng Zhang
Native LDL-Cholesterol Mediated Monocyte Adhesion Molecule Overexpression is Blocked by Simvastatin
Carlos V. Serrano Jr., Antônio Eduardo Pesaro, James A. de Lemos, Fabiana Rached, C. Alexandre Segre, Fernando Gomes, Adriano F. Ribeiro, José Carlos Nicolau, Vanda M. Yoshida, Hugo P. Monteiro
Impact of Nesiritide on Renal Function and Mortality in Patients Suffering from Heart Failure
Ioannis D. Dontas, Theodoros Xanthos, Ismene Dontas, Pavlos Lelovas, Lila Papadimitriou
Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the I f Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome—RIVIERA Trial Study Design and Rationale
Alberto Dominguez-Rodriguez, Sima Samimi Fard, Pedro Abreu-Gonzalez, Francisco Bosa-Ojeda, Luciano Consuegra-Sanchez, Alejandro Jiménez-Sosa, Alejandro Sánchez Grande, Juan Carlos Kaski
Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions
Michel Romanens, Franz Ackermann, Michael Abay, Thomas Szucs, Matthias Schwenkglenks